THE VALUE OF NEW INFLAMMATORY PARAMETERS IN MALIGNANT MESOTHELIOMA PROGNOSIS

Basit Öğe Kaydı
dc.contributor.authorTanrikulu, Abdullah Cetin
dc.contributor.authorHocanli, Iclal
dc.contributor.authorYilmaz, Ahmet
dc.contributor.authorMeteroglu, Fatih
dc.contributor.authorTaylan, Mahsuk
dc.contributor.authorDemir, Melike
dc.contributor.authorKaya, Halide
dc.date.accessioned2024-04-24T17:44:23Z
dc.date.available2024-04-24T17:44:23Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractAim: Malignant mesothelioma (MM) has a poor prognosis. Inflammation is associated with MM prognosis and symptoms. Several inflammatory markers were investigated to estimate MM prognosis. We investigated the role of available inflammatory index and markers for MM prognosis. We developed the advanced mesothelioma index (AMI) to assess the degree of inflammation in MM. Materials and methods: We performed a retrospective study of 202 MM patients (116, male, 86 female) evaluated at Dicle University. Demographic parameters and laboratory data were collected. The AMI was calculated as Body Mass Index*serum albumin value (g/dl)/platelet-to-lymphocyte ratio. Results: The mean age of patients was 59.04 years. A total of 135 (66.8%) patients showed epithelial-type histopathological subtypes and 177 patients had pleural MM. The mean survival time was 13.1 +/- 11.5 months in the all MM patients. Twenty-four potential prognostic factors were associated with a poor outcome and then analyzed in the univariate analysis. Eighteen of them were definitely associated with a poor prognosis. These 18 potential prognostic factors were analyzed in the multivariate analysis. Based on the results of the multivariate analysis, only patients with an AMI<0.5 had an associated poor prognosis. An AMI<0.5 increased the mortality rate by 10.47. Furthermore, low AMI was associated with other bad inflammatory markers (such as high platelet count, high C reactive protein level, low Body Mass Index, low albumin and low hemoglobin). Conclusion: Our findings indicate that the AMI can be used to assess the degree of systemic inflammation.en_US
dc.identifier.endpage15en_US
dc.identifier.issn0393-6384
dc.identifier.issn2283-9720
dc.identifier.issue1en_US
dc.identifier.startpage9en_US
dc.identifier.urihttps://hdl.handle.net/11468/21994
dc.identifier.volume31en_US
dc.identifier.wosWOS:000346319200001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherCarbone Editoreen_US
dc.relation.ispartofActa Medica Mediterranea
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMalignant Mesotheliomaen_US
dc.subjectInflammationen_US
dc.subjectAdvanced Mesothelioma Indexen_US
dc.titleTHE VALUE OF NEW INFLAMMATORY PARAMETERS IN MALIGNANT MESOTHELIOMA PROGNOSISen_US
dc.titleTHE VALUE OF NEW INFLAMMATORY PARAMETERS IN MALIGNANT MESOTHELIOMA PROGNOSIS
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu